Biomarin Pharmaceutical Inc (BMRN)
66.60
+0.71
(+1.08%)
USD |
NASDAQ |
Nov 01, 16:00
66.60
0.00 (0.00%)
After-Hours: 20:00
Biomarin Pharmaceutical Gross Profit Margin (Quarterly): 74.73% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 74.73% |
| June 30, 2024 | 81.68% |
| March 31, 2024 | 80.71% |
| December 31, 2023 | 81.32% |
| September 30, 2023 | 77.97% |
| June 30, 2023 | 78.06% |
| March 31, 2023 | 77.29% |
| December 31, 2022 | 76.32% |
| September 30, 2022 | 76.99% |
| June 30, 2022 | 76.93% |
| March 31, 2022 | 77.48% |
| December 31, 2021 | 73.38% |
| September 30, 2021 | 74.67% |
| June 30, 2021 | 74.67% |
| March 31, 2021 | 75.28% |
| December 31, 2020 | 72.10% |
| September 30, 2020 | 60.40% |
| June 30, 2020 | 77.19% |
| March 31, 2020 | 77.82% |
| December 31, 2019 | 78.90% |
| September 30, 2019 | 78.97% |
| June 30, 2019 | 80.03% |
| March 31, 2019 | 77.75% |
| December 31, 2018 | 78.76% |
| September 30, 2018 | 79.86% |
| Date | Value |
|---|---|
| June 30, 2018 | 78.81% |
| March 31, 2018 | 77.95% |
| December 31, 2017 | 78.79% |
| September 30, 2017 | 82.20% |
| June 30, 2017 | 82.26% |
| March 31, 2017 | 83.54% |
| December 31, 2016 | 78.62% |
| September 30, 2016 | 81.87% |
| June 30, 2016 | 82.80% |
| March 31, 2016 | 81.79% |
| December 31, 2015 | 78.92% |
| September 30, 2015 | 83.29% |
| June 30, 2015 | 84.78% |
| March 31, 2015 | 84.72% |
| December 31, 2014 | 83.34% |
| September 30, 2014 | 83.05% |
| June 30, 2014 | 83.73% |
| March 31, 2014 | 84.95% |
| December 31, 2013 | 88.24% |
| September 30, 2013 | 79.50% |
| June 30, 2013 | 83.50% |
| March 31, 2013 | 83.98% |
| December 31, 2012 | 79.89% |
| September 30, 2012 | 80.78% |
| June 30, 2012 | 80.99% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
60.40%
Minimum
Sep 2020
81.68%
Maximum
Jun 2024
76.19%
Average
77.09%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 75.51% |
| Bristol-Myers Squibb Co | 75.13% |
| Alnylam Pharmaceuticals Inc | 82.85% |
| Bioventus Inc | 68.54% |
| Moderna Inc | 47.96% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.29% |
| Return on Assets | 4.69% |
| Return on Invested Capital | 5.27% |
| Profit Margin (Quarterly) | 14.22% |
| Operating Margin (Quarterly) | 15.27% |
| Return on Net Operating Assets | 8.77% |